Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Showing 1 - 13 of 26

View by: Cover Page List Articles

Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma

Dorothy Benton, Hoi Yee Chow, Sofiia Karchugina, Jonathan Chernoff

Merlin tumor suppressor function is regulated by PIP2-mediated dimerization

Robert F. Hennigan, Craig S. Thomson,  [ ... ], Nancy Ratner

Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

Long-Sheng Chang, Janet L. Oblinger,  [ ... ], on behalf of the Synodos for NF2 Consortium

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2

The Synodos for NF2 Consortium , Robert Allaway,  [ ... ], Wen-Ning Zhao

Characterization and utilization of an international neurofibromatosis web-based, patient–entered registry: An observational study

Mindell Seidlin, Robert Holzman,  [ ... ], on behalf of the Children’s Tumor Foundation

Genomic profile of human meningioma cell lines

Yu Mei, Wenya Linda Bi,  [ ... ], Ian F. Dunn

Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration

Alexander Schulz, Robert Büttner,  [ ... ], Helen Morrison

Save this journal alert
Log in to create a weekly email alert for: Neurofibromatosis type 2
Save this journal alert
Create a weekly email alert for: Neurofibromatosis type 2
You can change these options by clicking profile then "Alerts and Notifications"